Left Menu
Development News Edition

UPDATE 2-White House kills rebate rule aimed at lowering drug prices

Reuters | Updated: 11-07-2019 19:21 IST | Created: 11-07-2019 19:10 IST
UPDATE 2-White House kills rebate rule aimed at lowering drug prices
Representative image Image Credit: ANI

The Trump administration has withdrawn a rule that it had said would lower drug prices by ending the system of prescription drug after-market discounts called rebates that drugmakers pay to pharmacy benefit managers.

Shares of Cigna Corp, the largest U.S. pharmacy benefit manager, were up 13.5 percent in early Thursday trading. The move is a setback for the administration, which first launched the idea of eliminating the "safe harbour" protections for the payments last summer as part of a drug pricing "blueprint" aimed at bringing down costs, an important election issue for President Donald Trump.

The rule would have forced healthcare companies like Cigna and CVS Corp to forgo these discounts or pass them onto Medicare patients through their health insurance plans and drug plans. The companies said that would force them to raise monthly premiums. The rule, which was in the process of being finalized and would have gone into place next year, was estimated by the nonpartisan Congressional Budget Office to cost the government $177 billion over the next 10 years. The CBO also said that it was likely that drugmakers would not cut their prices because of the rule.

Shares of UnitedHealth Group Inc and CVS Health Corp were also up as were those of drug distributors like McKesson Corp and pharmacy Walgreens Boots Alliance Inc . "Political momentum was building against the 2020 implementation of the CMS proposal to eliminate pharmaceutical rebates in government programs due to the perceived unintended windfall profits that might have accrued to pharmaceutical manufacturers," JP Morgan analyst Gary Taylor wrote in a research note.

Politico https://www.politico.com/story/2019/07/11/white-house-drug-rebate-rule-1405884 reported the news on Thursday and the White House confirmed the decision to Reuters. In recent weeks, Politico and other publications reported that the White House and Health and Human Services Secretary Alex Azar disagreed over the rule.

"Based on careful analysis and thorough consideration, the President has decided to withdraw the rebate rule," White House spokesman Judd Deere said in an emailed statement. "The Trump administration is encouraged by continuing bipartisan conversations about legislation to reduce outrageous drug costs imposed on the American people, and President Trump will consider using any and all tools to ensure that prescription drug costs will continue to decline," he said.


TRENDING

OPINION / BLOG / INTERVIEW

3D printing and the future of manufacturing post COVID-19

The on-demand, customizable, and localized manufacturing of product components facilitated by 3D printing has the potential to redefine manufacturing but there are certain technical, mechanical, and legal limitations that, unless ...

How UK’s 'best prepared' healthcare system failed to gauge COVID-19

The UK is proud of their public health system and its unlike any other country as around 90 percent of British public supports the founding principles of National Health Service. But without accurate data being available to stakeholders in ...

Poor on IHR capacity progress in 2019, WHO says Cambodia tops COVID-19 response

Despite being in proximity to Hubei, the original epicenter of COVID-19 pandemic, Cambodia has reported just 226 confirmed cases and zero deaths. After seeing the data, WHO appreciated Cambodias healthcare information system but experts dou...

Loopholes in Healthcare Information System may have failed Singapore COVID-19 model

In the initial days of the COVID-19 outbreak, Singapore was in the limelight for its effective healthcare system and pandemic response plan. However, Singapore has now joined the list of the worst-hit nations and the situation is even worse...

Videos

Latest News

Delhi HC allows using dummy phone number for COVID-19 testing of homeless mentally ill

The Delhi High Court on Friday gave its nod for the use of 9999999999 as a dummy phone number and address of labs or hospitals for COVID-19 testing of homeless mentally ill patients after the submissions were made by the Indian Council for ...

Won't attend mosque inauguration, says Adityanath; SP asks him to apologise

The Samajwadi Party on Friday sought an apology from Uttar Pradesh Chief Minister Yogi Adityanath over his remark that he would not attend the inauguration of the mosque to be built in Ayodhya, replacing the demolished Babri Masjid. After t...

Chairman of Panihati municipality board of administrartors dies of COVID-19

Chairman of the board of administrators of Panihati municipality, Swapan Ghosh died of coronavirus at a private hospital Thursday, his family sources said. He was 66 and a bachelor.Ghosh was detected to be corona positive on August 4 and wa...

COVID-19: Facebook extends remote work for employees till July 2021

Tech giant Facebook on Friday announced an extension to its remote work policy for its employees till July 2021 owing to the coronavirus pandemic.According to The Verge, Facebook now joins other companies like Google that have also allowed ...

Give Feedback